E-THERAPEUTICS PLC

Active London

Other research and experimental development on natural sciences and engineering

40 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
E

E-THERAPEUTICS PLC

Other research and experimental development on natural sciences and engineering

Founded 15 Oct 2001 Active London, England 40 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering

Previous Company Names

E-THERAPEUTICS PLC 21 Sept 2007 — 18 Sept 2025
INROTIS TECHNOLOGIES LIMITED 18 Mar 2003 — 21 Sept 2007
E-THERAPEUTIC SYSTEMS LIMITED 13 Nov 2001 — 18 Mar 2003
CROSSCO (643) LIMITED 15 Oct 2001 — 13 Nov 2001
Accounts Submitted 6 Jun 2025 Next due 31 Jul 2026 1 month remaining
Confirmation Submitted 24 Oct 2025 Next due 29 Oct 2026 4 months remaining
Net assets £36M £14M 2024 year on year
Total assets £38M £13M 2024 year on year
Total Liabilities £2M £859K 2024 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

4 Kingdom Street London W2 6BD England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for E-THERAPEUTICS PLC (04304473), an active life sciences and medical technology company based in London, England. Incorporated 15 Oct 2001. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Feb → 31 Jan 2025
Type full
Next accounts 31 Jan 2026
Due by 31 Jul 2026 1 month remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£32.72M

Increased by £12.06M (+58%)

Net Assets

£36.07M

Increased by £14.08M (+64%)

Total Liabilities

£2.12M

Decreased by £859.00k (-29%)

Turnover

N/A

Decreased by £318.00k (-100%)

Employees

40

Increased by 5 (+14%)

Debt Ratio

6%

Decreased by 6 (-50%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Jan Year End
2024
31 Jan Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 1Mar 2009Strategic Investment
Investor 2Mar 2009Strategic Investment
Investor 3Jul 2024IPO

Share Capital

Share Capital

Share allotments and capital structure

10 Allotments 4,029,951 Shares £581k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Jan 201859,460£6k£0.093
3 Jan 201736,917£3k£0.075
5 Oct 201641,204£5k£0.113
21 Sept 20168,864£1k£0.146
1 Aug 201615,568£2k£0.146

Officers

Officers

1 active 2 resigned
Status
Trevor JonesDirectorBritishEngland8328 Oct 2015Active

Shareholders

Shareholders (1)

All Shareholders
100.0%
777,147,480

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Invesco Ltd

Ceased 28 Oct 2019

Ceased

Group Structure

Group Structure

E-THERAPEUTICS PLC Current Company
SEARCHBOLT LIMITED united kingdom

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 Jun 2026OfficersTermination of Ahmad Ali Mortazavi as director on 30 Mar 2026
24 Oct 2025Confirmation StatementConfirmation statement made on 15 Oct 2025 with updates
18 Sept 2025Change Of NameCertificate Change Of Name Company
7 Aug 2025CapitalAllotment of shares (GBP 777,147.48) on 28 Jul 2025
6 Jun 2025AccountsAnnual accounts made up to 31 Jan 2025
1 Jun 2026 Officers

Termination of Ahmad Ali Mortazavi as director on 30 Mar 2026

24 Oct 2025 Confirmation Statement

Confirmation statement made on 15 Oct 2025 with updates

18 Sept 2025 Change Of Name

Certificate Change Of Name Company

7 Aug 2025 Capital

Allotment of shares (GBP 777,147.48) on 28 Jul 2025

6 Jun 2025 Accounts

Annual accounts made up to 31 Jan 2025

Recent Activity

Latest Activity

Termination of Ahmad Ali Mortazavi as director on 30 Mar 2026

3 days ago on 1 Jun 2026

Confirmation statement made on 15 Oct 2025 with updates

7 months ago on 24 Oct 2025

Certificate Change Of Name Company

8 months ago on 18 Sept 2025

Allotment of shares (GBP 777,147.48) on 28 Jul 2025

10 months ago on 7 Aug 2025

Annual accounts made up to 31 Jan 2025

12 months ago on 6 Jun 2025